help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on May 16, 2006
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2006-0503
A more recent version of this article appeared on August 1, 2006
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
91/8/2867    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Van, P. L.
Right arrow Articles by Bondy, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Van, P. L.
Right arrow Articles by Bondy, C. A.

Submitted on March 6, 2006
Accepted on May 9, 2006

MONOSOMY FOR THE X-CHROMOSOME IS ASSOCIATED WITH AN ATHEROGENIC LIPID PROFILE

Phillip L. Van MS, Vladimir K. Bakalov MD, and Carolyn A. Bondy MD*

Developmental Endocrinology Branch, NICHD, NIH, Bethesda, MD

* To whom correspondence should be addressed. E-mail: bondyc{at}mail,nih.gov.

Context & Objective

Men typically have a more atherogenic lipid profile than women characterized by higher LDL-cholesterol and triglyceride levels and reduced lipid particle size, contributing to a greater risk for coronary disease. To determine if X-chromosomal gene dosage affects lipid metabolism independent of sex steroid effects, we compared lipid profiles in age- and body mass-matched young women with ovarian failure, differing only in X-chromosome dosage.

Design, setting & patients

Women with premature ovarian failure associated with monosomy X, or Turner syndrome (TS, n = 118) were compared with women with 46,XX premature ovarian failure (POF, n = 51) in an in-patient CRC unit at the NIH. These women were normally on estrogen replacement treatment, but discontinued the estrogen two weeks before study.

Major outcomes

Fasting lipid levels and NMR lipid particle profiles in the two study groups

Results

Average age and body mass were similar in the two groups of women, but LDL-cholesterol (P = 0.001) and triglyceride levels (P = 0.0005) were higher in the TS group. Also among women with TS, average LDL particle size was reduced (P < 0.0001) and LDL particle concentration increased, with a 2-fold increase in the smallest particle categories (P < 0.0001). While total HDL-cholesterol levels were similar, HDL particle size was significantly smaller in women with TS compared with women with POF (P < 0.0001).

Conclusions

45,X women with ovarian failure exhibit a distinctly more atherogenic lipid profile than 46,XX women with ovarian failure, suggesting the second X-chromosome contributes to a more salutary lipid profile in normal women, independent of sex steroid effects.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
C. A. Bondy and for The Turner Syndrome Consensus Study Group
Care of Girls and Women with Turner Syndrome: A Guideline of the Turner Syndrome Study Group
J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 10 - 25.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society